Resected non-small-cell lung cancer stage I/II: indication for adjuvant/ neoad j uvant therapy?
- 31 August 2004
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 45, S91-S97
- https://doi.org/10.1016/j.lungcan.2004.07.986
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Second primary tumors following adjuvant therapy of resected stages II and IIIa non-small cell lung cancerLung Cancer, 2003
- The risk of second primary tumors after resection of stage I nonsmall cell lung cancerThe Annals of Thoracic Surgery, 2003
- Induction of Tumor Cell Apoptosis In Vivo Increases Tumor Antigen Cross-Presentation, Cross-Priming Rather than Cross-Tolerizing Host Tumor-Specific CD8 T CellsThe Journal of Immunology, 2003
- Clinicopathological analysis of prognostic factors in clinical IA peripheral adenocarcinoma of the lungThe Annals of Thoracic Surgery, 2003
- Lung Cancer in Japan: Analysis of Lung Cancer Registry for Resected Cases in 1994.Haigan, 2002
- The role of chemotherapy in early-stage (stage I and II) resectable non-small cell lung cancerSeminars in Radiation Oncology, 2000
- Prognostic factors in clinical stage I non–small cell lung cancerThe Annals of Thoracic Surgery, 1999
- Revisions in the International System for Staging Lung CancerChest, 1997
- Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies.Journal of Clinical Oncology, 1984
- Postoperative radiation therapy in lung cancer: A controlled trial after resection of curative designInternational Journal of Radiation Oncology*Biology*Physics, 1980